首页 | 本学科首页   官方微博 | 高级检索  
检索        

左旋奥硝唑在人体内的构型转化及药动学研究
引用本文:余鹏,郭歆,刘星菱,罗茜,陈婕,程泽能.左旋奥硝唑在人体内的构型转化及药动学研究[J].药物分析杂志,2011(5).
作者姓名:余鹏  郭歆  刘星菱  罗茜  陈婕  程泽能
作者单位:中南大学药学院;
摘    要:目的:研究左旋奥硝唑在健康人体内的构型转化及单次口服左旋奥硝唑的人体药代动力学。方法:24名健康志愿者,单剂量口服左旋奥硝唑片500 mg后72 h采集血浆样品,用手性拆分色谱柱分离、检测血浆中左旋奥硝唑与右旋奥硝唑;以高效液相色谱法测定血药浓度,用DAS ver 2.0软件计算药动学参数。结果:在给药后的健康志愿者体内未检出右旋奥硝唑。左旋奥硝唑人体内主要药动学参数分别为:Cmax=(28.86±8.77)mg.L-1,AUC0→t=(453.9±184.4)mg.h.L-1,Tmax=(0.57±0.36)h,V1/F=(31.7±15.4)L,CL/F=(2.42±0.69)L.h-1,t1/2β=(14.7±2.1)h,MRT=(17.6±1.8)h。结论:健康志愿者口服左旋奥硝唑后,在体内未发生构型转化。因而在对左旋奥硝唑血浆样品进行检测时,可以不必考虑消旋化带来的影响。

关 键 词:奥硝唑  手性拆分  构型转化  药动学  

Studies on chiral inversion and pharmacokinetics of laevo-ornidazole in human
YU Peng,GUO Xin,LIU Xing-ling,LUO Xi,CHEN Jie,CHENG Ze-neng.Studies on chiral inversion and pharmacokinetics of laevo-ornidazole in human[J].Chinese Journal of Pharmaceutical Analysis,2011(5).
Authors:YU Peng  GUO Xin  LIU Xing-ling  LUO Xi  CHEN Jie  CHENG Ze-neng
Institution:YU Peng,GUO Xin,LIU Xing-ling,LUO Xi,CHEN Jie,CHENG Ze-neng(School of Pharmaceutical Sciences,Central South University,Changsha 410013,China)
Abstract:Objective:To study the chiral inversion and pharmacokinetics of laevo-ornidazole in human.Methods:24 Chinese volunteers were administrated with an oral dose of 500 mg laevo-ornidazole.Then 3 mL blood was sampled after 72 h to detect the plasma concentrations of laevo-ornidazole and dextro-ornidazole on a chiral HPLC column.The pharmacokinetic parameters were measured by DAS ver 2.0 software.Results:Dextro-ornidazole was not found in all 24 plasma samples from different volunteers.The pharmacokinetic paramet...
Keywords:ornidazole  enantiomeric separation  chiral inversion  pharmacokinetics  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号